CathRx is an Australian-based medical device company principally involved in the development and manufacture of innovative, low cost, high quality electrophysiology catheters for the diagnosis and treatment of cardiac arrhythmias.
The company’s proprietary technology platform circumvents the technological limitations associated with conventional single-use catheter design. The technology which is incorporated into the company’s new Khelix™ range of catheters, will help hospitals reduce their economic and environmental costs by allowing reprocessing of the catheters by their on-site central sterilisation departments.
The company is currently in the process of obtaining regulatory approval for its first release of diagnostic and therapeutic catheters, which are expected to meet 80% of the catheter needs of EP laboratories. The company is also actively pursuing strategic alliances with manufacturing and distribution partners.
Professor Prashanthan Sanders | MBBS (Hons), PhD, FRACP, FCSANZ, FESC, Chairman
Professor Sanders is a clinical academic and Professor of Medicine at University of Adelaide. He is currently the Director of the Centre for Heart Rhythm Disorders at the University of Adelaide, Director of Cardiac Electrophysiology at the Royal Adelaide Hospital, and the Group Leader for Heart Rhythm Disorders at the South Australian Health and Medical Research Institute.
Professor Jonathan Kalman | MBBS (Hons), PhD, FRACP, FCSANZ, FESC
Professor Kalman is the Scientific Chair of the Asia Pacific Heart Rhythm Society and the Cardiac Society of Australia and New Zealand. Professor Kalman is a clinical academic at the University of Melbourne and Professor of Medicine at The Royal Melbourne Hospital, the Head of Heart Rhythm at The Royal Melbourne Hospital, and consultant cardiologist and cardiac electrophysiologist at the Melbourne Heart Centre.
Dr Kelvin Hopper
Hin Choong Low
Dr. Omar Amirana